Immunophenotyping of T cells in the peripheral circulation in psoriasisFootnote

MP, DPD and SI have contributed equally to the study and hence are co-first authors for this research work.

References

• Cai Y, Fleming C, Yan J. New insights of T cells in the pathogenesis of psoriasis. Cell. Mol. Immunol. 2012;9:302–309.10.1038/cmi.2012.15
   PubMed Web of Science ®Google Scholar
• Yawalkar N, Karlen S, Hunger R, et al. Expression of interleukin-12 is increased in psoriatic skin. J. Invest. Dermatol. 1998;111:1053–1057.10.1046/j.1523-1747.1998.00446.x
   PubMed Web of Science ®Google Scholar
• Nickoloff BJ. Cracking the cytokine code in psoriasis. Nat. Med. 2007;13:242–244.10.1038/nm0307-242
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Nograles KE, Krueger JG. Contrasting pathogenesis of atopic dermatitis and psoriasis – Part II: Immune cell subsets and therapeutic concepts. J. Allergy. Clin. Immunol. 2011;127:1420–1432.10.1016/j.jaci.2011.01.054
   PubMed Web of Science ®Google Scholar
• Zhu K, Ye J, Wu M, et al. Expression of Th1 and Th2 cytokine-associated transcription factors, T-bet and GATA-3, in peripheral blood mononuclear cells and skin lesions of patients with psoriasis vulgaris. Arch. Dermatol. Res. 2010;302:517–523.10.1007/s00403-010-1048-1
   PubMed Web of Science ®Google Scholar
• Jacob SE, Nassiri M, Kerdel FA, et al. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators. Inflamm. 2003;12:309–313.10.1080/09629350310001619753
   PubMed Web of Science ®Google Scholar
• Guenova E, Skabytska Y, Hoetzenecker W, et al. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proceedings of the National Academy of Sciences of the United States of America. 2015;112:2163–2168.
   PubMed Web of Science ®Google Scholar
• Bonifati C, Ameglio F. Cytokines in psoriasis. Int. J. Dermatol. 1999;38:241–251.10.1046/j.1365-4362.1999.00622.x
   PubMed Web of Science ®Google Scholar
• Szabo SK, Hammerberg C, Yoshida Y, et al. Identification and quantitation of interferon-γ producing T Cells in psoriatic lesions: Localization to both CD4+ and CD8+ subsets. J. Invest. Dermatol. 1998;111:1072–1078.10.1046/j.1523-1747.1998.00419.x
   PubMed Web of Science ®Google Scholar
• Friedrich M, Krammig S, Henze M, et al. Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype. Arch. Dermatol. Res. 2000;292:519–521.10.1007/s004030000167
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang XQ, Cheng J, et al. Increased Th17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity. Clin. Immunol. 2010;135:108–117.10.1016/j.clim.2009.11.008
   PubMed Web of Science ®Google Scholar
• Jorn Bovenschen HJ, van de Kerkhof PC, van Erp PE, et al. Foxp3+ regulatory T Cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 2011;131:1853–1860.10.1038/jid.2011.139
   PubMed Web of Science ®Google Scholar
• Soler DC, Sugiyama H, Young AB, et al. Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset. Clin. Immunol. 2013;149:111–118.10.1016/j.clim.2013.06.007
   PubMed Web of Science ®Google Scholar
• Zhang HY, Yan KX, Huang Q, et al. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis. Clin. Exp. Dermatol. 2015;40:182–191.10.1111/ced.2015.40.issue-2
   PubMed Web of Science ®Google Scholar
• Quaglino P, Ortoncelli M, Comessatti A, et al. Circulating CD4+CD25 bright FOXP3+ T cells are upregulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatol. 2009;219:250–258.10.1159/000238305
   PubMed Web of Science ®Google Scholar
• Zhang L, Li Y, Yang X, et al. Characterization of Th17 and FoxP3 (+) Treg cells in pediatric psoriasis patients. Scand. J. Immunol. 2016;83:174–180.
   PubMed Web of Science ®Google Scholar
• Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J. Invest. Dermatol. 2008;128:1064–1067.10.1038/jid.2008.85
   PubMed Web of Science ®Google Scholar
• Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 2009;129:79–88.10.1038/jid.2008.194
   PubMed Web of Science ®Google Scholar
• Teunissen MB, Koomen CW, de Waal Malefyt R, et al. Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 1998;111:645–649.10.1046/j.1523-1747.1998.00347.x
   PubMed Web of Science ®Google Scholar
• Ortega C, Fernandez-A S, Carrillo JM, et al. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J. Leukoc. Biol. 2009;86:435–443.10.1189/JLB.0109046
   PubMed Web of Science ®Google Scholar
• Marinoni B, Ceribelli A, Massarotti MS, et al. The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications. Auto Immun Highlights. 2014;5:9–19.
   PubMedGoogle Scholar
• Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647–1656.10.1002/art.v60:6
   PubMed Web of Science ®Google Scholar
• Eysteinsdóttir JH, Sigurgeirsson B, Ólafsson JH, et al. The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response. Scand. J. Immunol. 2013;78:529–537.10.1111/sji.2013.78.issue-6
   PubMed Web of Science ®Google Scholar
• Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 2008;128:1207–1211.10.1038/sj.jid.5701213
   PubMed Web of Science ®Google Scholar
• Quaglino P, Bergallo M, Ponti R, et al. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: Modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology. 2011;223:57–67.10.1159/000330330
   PubMed Web of Science ®Google Scholar
• Karamehic J, Zecevic L, Resic H, et al. Immunophenotype lymphocyte of peripheral blood in patients with psoriasis. Med. Arch. 2014;68:236–238.10.5455/medarh.
   PubMedGoogle Scholar
• Griffiths CE, Christophers E, Barker JN, et al. A classification of psoriasis vulgaris according to phenotype. Br. J. Dermatol. 2007;156:258–262.10.1111/bjd.2007.156.issue-2
   PubMed Web of Science ®Google Scholar
• Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–2673.10.1002/(ISSN)1529-0131
   PubMed Web of Science ®Google Scholar
• Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment. J. Am. Acad. Dermatol. 2004;51:563–569.10.1016/j.jaad.2004.04.012
   PubMed Web of Science ®Google Scholar
• Szegedi A, Aleksza M, Gonda A, et al. Elevated rate of Thelper1 (TH1) lymphocytes and serum IFN-γ levels in psoriatic patients. Immunol. Lett. 2003;86:277–280.10.1016/S0165-2478(03)00025-7
   PubMed Web of Science ®Google Scholar
• Prens E, Hegmans J, Lien RC, et al. Increased expression of interleukin-4 receptors on psoriatic epidermal cells. Am. J. Pathol. 1996;148:1493–1502.
   PubMed Web of Science ®Google Scholar
• Jain S, Kaur IR, Das S, et al. T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J. Med. Microbiol. 2009;58:180–184.10.1099/jmm.0.003939-0
   PubMed Web of Science ®Google Scholar
• Kagami S, Rizzo HL, Lee JJ, et al. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 2010;130:1373–1383.10.1038/jid.2009.399
   PubMed Web of Science ®Google Scholar
• Benham H, Norris P, Goodall J, et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res. Ther. 2013;15:R136.10.1186/ar4317
   PubMed Web of Science ®Google Scholar
• Keijsers RR, van der Velden HM, van Erp PE, et al. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. Br. J. Dermatol. 2013;168:1294–1302.10.1111/bjd.2013.168.issue-6
   PubMed Web of Science ®Google Scholar
• Mehta NN, Dagur PK, Rose SM, et al. IL-17A production in human psoriatic blood and lesions by CD146+ T Cells. J. Invest. Dermatol. 2015;135:311–314.10.1038/jid.2014.317
   PubMed Web of Science ®Google Scholar
• Roh NK, Han SH, Youn HJ, et al. Tissue and serum inflammatory cytokine levels in korean psoriasis patients: A comparison between plaque and guttate psoriasis. Ann. Dermatol. 2015;27:738–743.10.5021/ad.2015.27.6.738
   PubMed Web of Science ®Google Scholar